These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27743567)

  • 21. MR imaging of the liver. Technique.
    Soyer P; Bluemke DA; Rymer R
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):205-21. PubMed ID: 9113672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging of benign focal liver lesions.
    Cogley JR; Miller FH
    Radiol Clin North Am; 2014 Jul; 52(4):657-82. PubMed ID: 24889166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic MR imaging techniques, optimization, and artifacts.
    Guglielmo FF; Mitchell DG; Roth CG; Deshmukh S
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):263-82. PubMed ID: 25086929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technique for MR imaging of the liver.
    Saini S; Nelson RC
    Radiology; 1995 Dec; 197(3):575-7. PubMed ID: 7480718
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contrast medium-supported sonography of the liver--a challenge to German radiology].
    Albrecht T
    Rofo; 2003 Jul; 175(7):889-91. PubMed ID: 12847642
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].
    Stroszczynski C; Gaffke G; Gnauck M; Streitparth F; Wieners G; Lopez-Häninnen E
    Radiologe; 2004 Dec; 44(12):1185-91. PubMed ID: 15549226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive liver imaging: new techniques and practical strategies.
    Longmaid HE; Dupuy DE; Kane RA; Finn JP; Costello P
    Semin Ultrasound CT MR; 1992 Oct; 13(5):377-98. PubMed ID: 1419142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential conditions causing impairment of selective hepatobiliary enhancement of gadobenate dimeglumine-enhanced delayed magnetic resonance imaging.
    Kim H; Kim MJ; Park MS; Cha SW; Lim JS; Yoo HS; Kim KW
    J Comput Assist Tomogr; 2010 Jan; 34(1):113-20. PubMed ID: 20118733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
    Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
    J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging after local tumor therapies: kidney and liver.
    Kielar AZ; Hibbert RM; Maturen KE
    Semin Roentgenol; 2013 Jul; 48(3):273-84. PubMed ID: 23796378
    [No Abstract]   [Full Text] [Related]  

  • 31. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W
    Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging of the liver: how I do it.
    Semelka RC; Martin DR; Balci NC
    J Gastroenterol Hepatol; 2006 Apr; 21(4):632-7. PubMed ID: 16677146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic Imaging in Neonates and Young Infants: State of the Art.
    Shamir SB; Kurian J; Kogan-Liberman D; Taragin BH
    Radiology; 2017 Dec; 285(3):763-777. PubMed ID: 29155636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic MR imaging with a dynamic contrast-enhanced isotropic volumetric interpolated breath-hold examination: feasibility, reproducibility, and technical quality.
    Lee VS; Lavelle MT; Rofsky NM; Laub G; Thomasson DM; Krinsky GA; Weinreb JC
    Radiology; 2000 May; 215(2):365-72. PubMed ID: 10796909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Sinusoidal Dilatation: A Review of Causes With Imaging-Pathologic Correlation.
    Furlan A; Minervini MI; Borhani AA; Dioguardi Burgio M; Tublin ME; Brancatelli G
    Semin Ultrasound CT MR; 2016 Dec; 37(6):525-532. PubMed ID: 27986171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver masses.
    Hussain SM; Semelka RC
    Magn Reson Imaging Clin N Am; 2005 May; 13(2):255-75. PubMed ID: 15935311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadolinium-enhanced imaging of liver tumors and manifestations of hepatitis: pharmacodynamic and technical considerations.
    Sharma P; Kitajima HD; Kalb B; Martin DR
    Top Magn Reson Imaging; 2009 Apr; 20(2):71-8. PubMed ID: 20010061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive lymphoid hyperplasia of the liver: Perinodular enhancement on contrast-enhanced computed tomography and magnetic resonance imaging.
    Sonomura T; Anami S; Takeuchi T; Nakai M; Sahara S; Tanihata H; Sakamoto K; Sato M
    World J Gastroenterol; 2015 Jun; 21(21):6759-63. PubMed ID: 26074715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver MR imaging: 1.5T versus 3T.
    Ramalho M; Altun E; Herédia V; Zapparoli M; Semelka R
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):321-47, vi. PubMed ID: 17893053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.